CORRECTA

Welcome to the Brand page for “CORRECTA”, which is offered here for Pharmaceutical preparations, proprietary retention enema formulation of the widely used topical antifungal agent clotrimazole for the treatment of acute refractory pouchitis, a subset of inflammatory bowel disease that is related to ulcerative colitis;.

Its status is currently believed to be active. Its class is unavailable. “CORRECTA” is believed to be currently owned by “Pipex Pharmaceuticals, Inc.”


Owner:
PIPEX PHARMACEUTICALS, INC.
Owner Details
Description:
Pharmaceutical preparations, proprietary retention enema formulation of the widely used topical antifungal agent clotrimazole for the treatment of acute refractory pouchitis, a subset of inflammatory bowel disease that is related to ulcerative colitis;
Categories: PHARMACEUTICAL PREPARATIONS